Evaluation of the Condition of Rheumatoid Arthritis After Treatment
NCT02157012 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2021-09-21
Summary
To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
Conditions
Interventions
- DRUG
-
The effectiveness of Xeljanz in rheumatoid arthritis patients
Sponsors & Collaborators
-
Showa Inan General Hospital
collaborator OTHER -
Shinshu University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2022-04-30
- Completion
- 2025-03-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis
NCT01225393 ·Status: COMPLETED ·Phase: PHASE2
-
Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)
NCT03885037 ·Status: COMPLETED
-
Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
NCT00235833 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
NCT00299546 ·Status: COMPLETED ·Phase: PHASE3
-
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy
NCT00973479 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
NCT05428488 ·Status: RECRUITING ·Phase: PHASE3
-
A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
NCT00484289 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT01248780 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)
NCT01181050 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
NCT00345748 ·Status: COMPLETED ·Phase: PHASE2
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
NCT01001832 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00578305 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT00264550 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX
NCT03975790 ·Status: COMPLETED
-
Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)
NCT00144521 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
NCT00264537 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs
NCT03355872 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis
NCT01244958 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Adherence of Golimumab in Rheumatoid Arthritis
NCT04188249 ·Status: UNKNOWN
-
An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
NCT00896168 ·Status: COMPLETED ·Phase: PHASE4
-
Rheumatologic Adverse Events and Cancer Immunotherapy
NCT04791150 ·Status: UNKNOWN ·Phase: NA
-
Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients
NCT01915537 ·Status: UNKNOWN ·Phase: NA
-
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
NCT02037737 ·Status: COMPLETED
-
Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients
NCT03254966 ·Status: COMPLETED ·Phase: PHASE2